Cargando…
The antihyperlipidemic effects of fullerenol nanoparticles via adjusting the gut microbiota in vivo
BACKGROUND: Nanoparticles (NPs) administered orally will meet the gut microbiota, but their impacts on microbiota homeostasis and the consequent physiological relevance remain largely unknown. Here, we describe the modulatory effects and the consequent pharmacological outputs of two orally administe...
Autores principales: | Li, Juan, Lei, Runhong, Li, Xin, Xiong, Fengxia, Zhang, Quanyang, Zhou, Yue, Yang, Shengmei, Chang, Yanan, Chen, Kui, Gu, Weihong, Wu, Chongming, Xing, Gengmei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5773151/ https://www.ncbi.nlm.nih.gov/pubmed/29343276 http://dx.doi.org/10.1186/s12989-018-0241-9 |
Ejemplares similares
-
Effects of Fullerenol Nanoparticles on Rat Oocyte Meiosis Resumption
por: Lei, Runhong, et al.
Publicado: (2018) -
Lipid- and gut microbiota-modulating effects of graphene oxide nanoparticles in high-fat diet-induced hyperlipidemic mice
por: Li, Juan, et al.
Publicado: (2018) -
Small size fullerenol nanoparticles suppress lung metastasis of breast cancer cell by disrupting actin dynamics
por: Qin, Yanxia, et al.
Publicado: (2018) -
The Gut Microbiota-Produced Indole-3-Propionic Acid Confers the Antihyperlipidemic Effect of Mulberry-Derived 1-Deoxynojirimycin
por: Li, Yougui, et al.
Publicado: (2020) -
On mechanism of antioxidant effect of fullerenols
por: Sachkova, A.S., et al.
Publicado: (2016)